Regulatory & Compliance

Elevance Loses $375M in Medicare Star Ratings Lawsuit
Regulatory & Compliance Elevance Loses $375M in Medicare Star Ratings Lawsuit

Setting the Stage: A Pivotal Loss in a High-Stakes Market In a landscape where every fraction of a star rating can translate to millions in revenue, Elevance Health, one of America's leading health insurers, has suffered a staggering $375 million setback due to a federal court ruling on its

White House Health Data Plan Lacks Key Implementation Details
Digital Health White House Health Data Plan Lacks Key Implementation Details

Imagine a healthcare system where patient records flow seamlessly between providers, empowering individuals to manage their health with ease through digital tools, a vision recently put forth by the Trump administration to revolutionize interoperability in the U.S. healthcare landscape through a

FDA Breakthrough Devices Spark Medicare Coverage Debate
Regulatory & Compliance FDA Breakthrough Devices Spark Medicare Coverage Debate

Imagine a world where a life-saving medical device, designed to treat a debilitating condition, is fast-tracked for approval but remains out of reach for many seniors due to coverage limitations. This scenario is a reality for numerous patients under the current U.S. Food and Drug Administration

CVS Caremark Ordered to Pay $290M for Medicare Fraud
Regulatory & Compliance CVS Caremark Ordered to Pay $290M for Medicare Fraud

I'm thrilled to sit down with James Maitland, a renowned expert in healthcare policy and regulation, with a particular focus on pharmacy benefit management and Medicare fraud. With years of experience analyzing the intersection of healthcare systems and legal accountability, James offers a unique

Democrats Slam CMS Prior Authorization Pilot in Medicare
Regulatory & Compliance Democrats Slam CMS Prior Authorization Pilot in Medicare

What happens when a trusted safety net for millions of seniors and disabled Americans faces a radical policy shift that could fundamentally alter access to care? A storm of controversy has erupted over a new pilot program by the Centers for Medicare & Medicaid Services (CMS) that introduces prior

UnitedHealth's $3.3B Amedisys Deal Sparks Controversy
Regulatory & Compliance UnitedHealth's $3.3B Amedisys Deal Sparks Controversy

I'm thrilled to sit down with James Maitland, a renowned expert in healthcare mergers and acquisitions with a deep understanding of antitrust regulations and their impact on the industry. With years of experience analyzing complex deals, James offers unparalleled insights into how these

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later